v3.26.1
Acquisition of Astria Therapeutics, Inc. - Narrative (Details)
$ / shares in Units, $ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Jan. 23, 2026
USD ($)
$ / shares
Jun. 30, 2026
USD ($)
$ / shares
Mar. 31, 2026
USD ($)
Jun. 30, 2025
USD ($)
Jun. 30, 2026
USD ($)
$ / shares
Jun. 30, 2025
USD ($)
Dec. 31, 2025
USD ($)
$ / shares
Business Combination [Line Items]              
Common stock par value (in usd per share) | $ / shares   $ 0.01     $ 0.01   $ 0.01
Acquired in-process research and development   $ 0   $ 0 $ 697,761 $ 0  
Amortization of assembled workforce         600 $ 0  
Astria              
Business Combination [Line Items]              
Stock conversion ratio (per share) 0.59            
Cash conversion ratio (in usd per share) | $ / shares $ 8.55            
Direct transaction costs             $ 7,506
Acquired in-process research and development $ 705,267       697,761    
Intangible asset, useful life 2 months            
Amortization of assembled workforce         600    
Stock price utilized for payout of acquiree stock options | $ / shares $ 13.00            
Payout of acquiree stock options, amount $ 43,403            
Payout of acquiree stock options, pre-combination service, amount 14,274            
Payout of acquiree stock options, post-combination service, amount $ 29,129            
Restructuring charges     $ 11,927   11,927    
Astria | Income Statement Location [Axis]: us-gaap:ResearchAndDevelopmentExpense              
Business Combination [Line Items]              
Payout of acquiree stock options, post-combination service, amount         10,709    
Restructuring charges         3,954    
Astria | Income Statement Location [Axis]: us-gaap:SellingGeneralAndAdministrativeExpense              
Business Combination [Line Items]              
Payout of acquiree stock options, post-combination service, amount         18,420    
Restructuring charges         $ 7,973    
Astria | Astria              
Business Combination [Line Items]              
Common stock par value (in usd per share) | $ / shares $ 0.001